- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00734981
Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System
June 22, 2011 updated by: Lotus Bio Inc.
Evaluation of specificity and sensitivity of Seaforia- an vitro diagnostic system for evaluating semen quality.
Study Overview
Status
Unknown
Conditions
Detailed Description
Quantities assessment of semen quality as defined by:
Semen volume, semen pH, leukocytes concentration, sperm cells concentration, motile sperm cell concentration, total motile sperm cells threshold and sperm cells morphology
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Arik kahana, Md.
- Phone Number: 972-3-5201527
- Email: arikk@assuta.com
Study Contact Backup
- Name: Irena Glass
- Phone Number: 972-3-7643064
- Email: irenag@assuta.co.il
Study Locations
-
-
-
tel Aviv, Israel, 67443
- Assuta Medical Centers Ltd.
-
Contact:
- Arik kahana, Md.
- Phone Number: 972-3-5201527
- Email: arikk@assuta.com
-
Contact:
- Irina Glass, xxx
- Phone Number: 972-3-7643064
- Email: irenag@asuuta.co.il
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Male volunteers
Description
Inclusion Criteria:
- Capable and willing to sign a consent form and participate in the study
- 20<Age<45
- Male
Exclusion Criteria:
None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Semen Quality as determined by the following parameters: Semen volume
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Semen pH
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Leukocytes concentration
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Sperm cells concentration
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Motile sperm cell concentration
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Total motile sperm cells threshold
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Sperm cells morphology
Time Frame: The same day as sevan evaluation according to the gold standard
|
The same day as sevan evaluation according to the gold standard
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Anticipated)
June 1, 2012
Study Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
August 12, 2008
First Submitted That Met QC Criteria
August 13, 2008
First Posted (Estimate)
August 14, 2008
Study Record Updates
Last Update Posted (Estimate)
June 23, 2011
Last Update Submitted That Met QC Criteria
June 22, 2011
Last Verified
June 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- LBI-02-V2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Male Fertility
-
Sandstone DiagnosticsCompletedFertility, Male | Sub-Fertility, MaleUnited States
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationCompletedFertility Disorders | Sub Fertility, Male | Sperm Count, LowGermany
-
IVI MadridRecruitingSperm | Sperm DNA Fragmentation | Male Fertility | TelomeresSpain
-
Rigshospitalet, DenmarkTerminatedFertility DisordersDenmark
-
University Hospital, ToulouseCompleted
-
University of California, San FranciscoRecruitingHealthy | Fertility Disorders | Male Infertility | Infertility, MaleUnited States
-
University of Sao PauloCompleted
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationTerminatedFertility Issues | Fertility Disorders | IVF | Sub Fertility, Female | Sub-fertilityGermany
-
University of California, Los AngelesCedars-Sinai Medical CenterCompletedFertility | Oligozoospermia | Asthenozoospermia | TeratozoospermiaUnited States
-
University of California, San FranciscoCompletedInfertility | Fertility Disorders | Infertility, Male | Infertility Unexplained | Sperm DNA Fragmentation | Embryo QualityUnited States